FLT1 and neoplasm: The term PMN was first coined by Kaplan et al. in 2005, in groundbreaking studies that showed the importance of Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)- expressing BMDCs in forming pre-metastatic sites in the lungs before the arrival of tumor cells [5].